Taizhou Women and Children's Hospital Co., Ltd. announced that it will issue common shares for gross proceeds CNY 231,182,800 on January 18, 2023. The transaction will include participation from returning investor, Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. The transaction has been approved at the the 15th session of the company?s 5th directorate and the 13th session of the company?s 5th supervisory board. After the capital increase, the registered capital will increase from CNY 86,956,500 to CNY 318,139,300.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 CNY | +1.99% | +1.87% | -35.12% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.12% | 455M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 603168 Stock
- News Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
- Taizhou Women and Children's Hospital Co., Ltd. announced that it expects to receive CNY 231.1828 million in funding from Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.